Liaoning Heshi Ophthalmic Hospital Group Co., Ltd
Initial public offering and listing on GEM
Suggestive announcement of listing announcement
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
With the approval of Shenzhen Stock Exchange, the RMB common shares issued by Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. (hereinafter referred to as “the issuer” or “the company”) will be listed on the gem of Shenzhen Stock Exchange on March 22, 2022, The full text of the listing announcement and the full text of the prospectus for initial public offering and listing on the gem are disclosed on the information disclosure website designated by the CSRC: http://www.cn.info.com.cn China Securities Network (www.cn. Stock. Com.) Securities Times (www.stcn. Com.) China Securities Network (www.cs. Com. CN.) Securities Daily (www.zqrb. CN.) And economic reference network (www.jjckb. CN.), For investors to consult.
QR code of web page: cninfo.com I. listing overview
(I) stock abbreviation: he ophthalmology
(II) Stock Code: 301103
(III) total share capital after IPO: 121558824 shares
(IV) number of initial public offering shares: 30.5 million shares. This issuance is all new shares without transfer of old shares.
2、 Risk tips
The company’s shares will be listed on the growth enterprise market of Shenzhen Stock Exchange, which has high investment risk. GEM companies have the characteristics of unstable performance, high operation risk and high delisting risk, and investors are facing greater market risk. Investors should fully understand the investment risks of the gem and the risk factors disclosed by the company, and make investment decisions prudently.
The issuing price of this offering is 42.50 yuan / share, which does not exceed the median and weighted average of offline investors’ quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, whichever is lower. According to the guidelines for Industry Classification of listed companies (revised in 2012) issued by China Securities Regulatory Commission, the industry of the issuer is “Q83 health”. The static average p / E ratio of Q83 health released by China Securities Index Co., Ltd. in the latest month is 67.50 times (as of March 7, T-3, 2022). The valuation levels of comparable listed companies are as follows:
T-3 day shares in 2020 minus the corresponding static city in 2020 minus the corresponding static City securities code securities abbreviation closing price non front EPS non back EPS earnings ratio minus non front earnings ratio minus non back (yuan / share) (yuan / share) (yuan / share) (2020) (2020)
Aier Eye Hospital Group Co.Ltd(300015) .SZ Aier Eye Hospital Group Co.Ltd(300015) 32.65 0.3189 0.3942 1023832 828260
3309. HK Xima ophthalmology 3.68 -0.0041 -0.0122 -8975610 -3016393
1846.hk deshijia 5.77 0.1598 0.1516361076380607
Mean value (excluding outliers – Xima Ophthalmology) 692454604433
Source: wind consulting, data as of March 7, 2022
Note 1: if there is mantissa difference in the calculation of P / E ratio, it is caused by rounding;
Note 2: EPS before / after deduction of non recurring profit and loss in 2020 = net profit attributable to the parent before / after deduction of non recurring profit and loss in 2020 / total share capital on T-3 day;
Note 3: since EPS before / after deduction of “Xima ophthalmology” is negative, it shall be excluded when calculating the average value of static P / E ratio before / after deduction; Note 4: the closing price of “Xima ophthalmology” and “deshijia” on T-3 and EPS before / after deduction in 2020 are measured in RMB, and the exchange rate adopts the central parity rate of the people’s Bank of China on March 7, 2022 (T-3).
After deducting the average p / E ratio of non current parent companies in 2020, which is 57.91 times lower than the average p / E ratio of non current parent companies before and after the issuance of the current year’s 3-month diluted P / E index in 2020, the net profit ratio of non current parent companies is still lower than that of the current year’s 3-month diluted P / E index in 2020.
In this offering, due to the substantial increase in the scale of net assets caused by the acquisition of raised funds, the return on net assets decreased, and the issuer’s production and operation mode, operation management and risk control ability, financial status and profitability were affected
The issuer and the recommendation institution (lead underwriter) remind investors to pay attention to investment risks, carefully study and judge the rationality of issuance pricing, and make investment decisions rationally. 3、 Contact information
(I) contact information of the issuer
Issuer: Liaoning Heshi Ophthalmic Hospital Group Co., Ltd
Contact address: 15011512, jiataihe international building, 118 Huanghe South Street, Huanggu District, Shenyang, Liaoning Province
Contact: Deng Ming
Tel.: 02423882921
Fax No.: 02423882921
(II) recommendation institution (lead underwriter)
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375)
Contact address: 18 / F, building 7, Yuetan Financial Street Holdings Co.Ltd(000402) center, yard 1, Yuetan South Street, Xicheng District, Beijing
Contact: Zhong Jiangang, Feng Jiangtao, Zou Ming
Tel: 01057058322
Fax: 01057058349
(there is no text on this page, which is the seal page of the suggestive announcement of the listing announcement of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. on its initial public offering and listing on the GEM)
Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. (no text on this page, which is the seal page of the suggestive announcement of the listing announcement of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. on its initial public offering and listing on the GEM)
Central China Securities Co.Ltd(601375) mm / DD / yyyy
